IgA Nephropathy
Symptoms, Doctors, Treatments, Advances & More

Save information for later
Sign Up

Learn About IgA Nephropathy

What is the definition of IgA Nephropathy?
IgA nephropathy is a kidney disorder that occurs when IgA (immunoglobulin A), a protein that helps the body fight infections, settles in the kidneys. In the early stages, IgA nephropathy has no symptoms. The first sign of this condition may be blood in the urine. End-stage kidney disease may develop. In most instances, the cause of this condition is unknown; however, certain disorders have been linked with IgA nephropathy, such as cirrhosis of the liver, celiac disease, and HIV infection. Although IgA nephropathy usually occurs in a family with no other affected members, several cases of familial IgA nephropathy have been reported. Familial IgA nephropathy is suspected to run through families in an autosomal dominant manner and is linked to genetic material on the long arm of chromosome 6 (6q22-23).
What are the alternative names for IgA Nephropathy?
  • IgA nephropathy
  • Berger disease
  • Berger's disease
  • Glomerulonephritis, IGA
  • IGAN
  • Nephritis, IGA type
Who are the top IgA Nephropathy Local Doctors?
Elite in IgA Nephropathy
Elite in IgA Nephropathy
Referral may be required

CUIMC/Russ Berrie Medical Science Pavilion

1150 St. Nicholas Avenue, 
New York, NY 
Languages Spoken:
English

Ali Gharavi is a Nephrologist practicing medicine in New York, New York. Dr. Gharavi is rated as an Elite provider by MediFind in the treatment of IgA Nephropathy. He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses IgA Nephropathy, Glomerulonephritis, Focal Segmental Glomerulosclerosis, Minimal Change Disease, and Kidney Transplant. Dr. Gharavi is board certified in Nephrology.

Elite in IgA Nephropathy
Elite in IgA Nephropathy
Referral required

Georgia Nephrology

595 Hurricane Shoals Road Northwest, 
Lawrenceville, GA 
Languages Spoken:
English
Accepting New Patients

James Tumlin is a Nephrologist practicing medicine in Lawrenceville, Georgia. Dr. Tumlin is rated as an Elite provider by MediFind in the treatment of IgA Nephropathy. He is also highly rated in 24 other conditions, according to our data. His clinical expertise encompasses IgA Nephropathy, Lupus Nephritis, Glomerulonephritis, Focal Segmental Glomerulosclerosis, and Kidney Transplant. Dr. Tumlin is board certified in American Board Of Internal Medicine, 1992, American Board Of Internal Medicine, and American Board Of Internal Medicine - Nephrology. Dr. Tumlin is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in IgA Nephropathy
Elite in IgA Nephropathy
Referral may be required

CUIMC/Herbert Irving Pavilion

161 Fort Washington Avenue, 
New York, NY 
Languages Spoken:
English, Italian, Spanish
Accepting New Patients
Offers Telehealth

Pietro Canetta is a Nephrologist practicing medicine in New York, New York. Dr. Canetta is rated as an Elite provider by MediFind in the treatment of IgA Nephropathy. He is also highly rated in 15 other conditions, according to our data. His clinical expertise encompasses Focal Segmental Glomerulosclerosis, Glomerulonephritis, Minimal Change Disease, IgA Nephropathy, and Kidney Transplant. Dr. Canetta is board certified in Internal Medicine and Nephrology. Dr. Canetta is currently accepting new patients.

What are the latest IgA Nephropathy Clinical Trials?
A Phase 2, Multicenter, Randomized, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of ARGX-121 SC in Adult Participants With Primary IgA Nephropathy

Summary: The study will assess how ARGX-121 affects immunoglobulin A nephropathy (IgAN) disease outcomes, such as renal function, how it is distributed and eliminated from the body, and how the immune system responds in adults with IgAN. While in the study, participants will continue to receive their usual medical care and medications for IgA nephropathy, unless the study doctor confirms otherwise. The stu...

Match to trials
Find the right clinical trials for you in under a minute
Get started
A Phase 3 Multicenter, Randomized, Double-Blind, Placebo Controlled Trial to Evaluate Efficacy and Safety of Mezagitamab (TAK-079) in Study Participants With Primary IgA Nephropathy in Combination With Stable Background Therapy

Summary: Immunoglobulin A nephropathy (IgAN) is a kidney condition. It happens when the body's immune system creates groups of proteins (called immune complexes) that build-up in the kidneys causing swelling (inflammation). Over time, this inflammation may lead to kidney damage and cause the kidneys to no longer work properly. The main aim of this study is to check how well mezagitamab changes protein leve...

Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center

What are the Latest Advances for IgA Nephropathy?